Log in

Relevant bibliographies by topics / Amisulpiride / Journal articles

To see the other types of publications on this topic, follow the link: Amisulpiride.

Journal articles on the topic 'Amisulpiride'

Author: Grafiati

Published: 3 June 2025

Last updated: 1 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 24 journal articles for your research on the topic 'Amisulpiride.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Chaudhari, Dhananjay, Ganesh Shanker, and Kunjan Gupta. "Amisulpiride induced tardive dyskinesia: a case report." International Journal of Research in Medical Sciences 6, no. 11 (2018): 3779. http://dx.doi.org/10.18203/2320-6012.ijrms20184187.

Full text

Abstract:

Amisulpride is a bezamide group of antipsychotic, and like other antipsychotics, it acts by reducing signalling via the dopamine D2 receptor. It is associated with a high risk, of developing increased blood levels of the lactation hormone, prolactin and low risk, as compared with typical antipsychotics, of causing movement disorders. Tardive dyskinesia is a type of movement disorder, which is more common with typical antipsychotics but development of tardive dyskinesia is not rare with the use of atypical antipsychotics. Newer molecules are being developed to reduce the incidence of various dy

APA, Harvard, Vancouver, ISO, and other styles

2

S, Arun, John Dinesh A, and Alok Pandey S. "AMISULPIRIDE INDUCED ERYTHEMA MULTIFORME: A CASE REPORT." Journal of Evolution of Medical and Dental Sciences 3, no. 40 (2014): 10053–56. http://dx.doi.org/10.14260/jemds/2014/3303.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Barak, Yoram, Shani Pridan, Yehuda Baruch, and Marnina Swartz. "Poster #M225 AMISULPIRIDE FOR ELDERLY PATIENTS WITH CHRONIC SCHIZOPHRENIA." Schizophrenia Research 153 (April 2014): S271—S272. http://dx.doi.org/10.1016/s0920-9964(14)70775-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Metin, �zmen, Kemal Yazici, Senel Tot, and Aylin Ertekin Yazici. "Amisulpiride augmentation in treatment resistant obsessive-compulsive disorder: an open trial." Human Psychopharmacology: Clinical and Experimental 18, no. 6 (2003): 463–67. http://dx.doi.org/10.1002/hup.512.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Reznik, I., S. Yadin, and A. Weizman. "The usage of new antipsychotics in treatment of schizophrenia with obsessive-compulsive symptoms." European Psychiatry 26, S2 (2011): 1490. http://dx.doi.org/10.1016/s0924-9338(11)73194-7.

Full text

Abstract:

BackgroundObsessive-compulsive (OC) symptoms have been observed in a substantial proportion of schizophrenic patients. Different etiopathological origins of OC symptoms make this type of schizophrenia to be a heterogeneous entity in phenomenological as well as in therapeutic aspects. The complex nature of the treatment response in this group of schizophrenic patients is as yet unclear.MethodsWe present a large case series study describes our experience with clozapine, risperidone, olanzapine, quetiapine, ziprazidone, amisulpiride, sertindole and paliperidone as a sole agents and in combination

APA, Harvard, Vancouver, ISO, and other styles

6

Li, Ming, Radek Budin, Alison S. Fleming, and Shitij Kapur. "Effects of novel antipsychotics, amisulpiride and aripiprazole, on maternal behavior in rats." Psychopharmacology 181, no. 3 (2005): 600–610. http://dx.doi.org/10.1007/s00213-005-0091-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Ismail, Nurazah, and Tuti Iryani Mohd Daud. "Concomitant Use of Antipsychotics and Diuretic Accelerates the Hyponatremia Effect." Malaysian Journal of Science Health & Technology 8 (September 21, 2022): 28–30. http://dx.doi.org/10.33102/mjosht.v8i.288.

Full text

Abstract:

We reported a case of severe symptomatic hyponatremia with a serum sodium level of 113 mmol/l after 2 weeks commencement of 2 types atypical antipsychotics; clozapine and amisulpiride with indapamide, a thiazide-like diuretic antihypertensive medication. Discontinuation of indapamide despite of continuation of his antipsychotics showed improvement in his serum sodium level. The aim of our case-report is to emphasize the life-threatening complication associated with the combination of agents that may cause hyponatremia. Both agents are known to cause electrolytes imbalance. Hence, close monitor

APA, Harvard, Vancouver, ISO, and other styles

8

Istikoglou, C., D. Foutsitzis, F. Papouli, et al. "P02-280 - The combination of Amisulpiride and Clozapine for the treatment of treatment-resistant schizophrenia." European Psychiatry 25 (2010): 915. http://dx.doi.org/10.1016/s0924-9338(10)70906-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Garde Gonzalez, J., P. Herrero Ortega, A. Oliva Lozano, M. A. Morillas Romerosa, and M. N. P. Soler. "Challenges in Managing Antipsychotic-Induced Hyperprolactinemia: A Case Study and Clinical Considerations for Aripiprazole Integration." European Psychiatry 67, S1 (2024): S127. http://dx.doi.org/10.1192/j.eurpsy.2024.296.

Full text

Abstract:

IntroductionCurrent guidelines for managing antipsychotic-induced hyperprolactinemia recommend the use of aripiprazole, either as a substitute or in combination with the primary antipsychotic. However, there have been reported cases of exacerbated psychotic symptoms when introducing aripiprazole after chronic treatment with another antipsychotic.ObjectivesWe present a case of a patient with unspecified schizophrenia spectrum disorder receiving amisulpride, who developed worsened psychotic symptoms following the introduction of aripiprazole to treat hyperprolactinemia. We also review this pheno

APA, Harvard, Vancouver, ISO, and other styles

10

Lai, Chien-Han. "Improvements in Micturition and Urinary Retention After Switching From Amisulpiride to Paliperidone in a Schizophrenic Patient." Journal of Neuropsychiatry and Clinical Neurosciences 24, no. 4 (2012): E11—E12. http://dx.doi.org/10.1176/appi.neuropsych.11090224.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

SK.Ammaji1, Sai Krishna L2 Naresh dola3 Ponugupati Tarun4 &. J.S.K.Nagarajan4. "STABILITY INDICATING BIOANALYTICAL METHOD AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF LEVOSULPIRIDE AND RABEPRAZOLE SODIUM IN HUMAN PLASMA BY RP-HPLC." International Journal of Medical Research and Pharmaceutical Sciences 5, no. 5 (2018): 6–18. https://doi.org/10.5281/zenodo.1256557.

Full text

Abstract:

<strong>Aim:</strong>  To developing, stability indicating validating bioanalytical method for the estimation of Levosulpiride and Rabeprazole Sodium by RP-HPLC method which is expected to be accurate, precise, linear, stable and selective Methods of measuring drugs in biologic media are increasingly important problems related to bioavailability and bioequivalence, new drug development, drug abuse, clinical pharmacokinetics, and drug research are highly dependent on accurately measured drugs in biological fluids. <strong>Method:</strong> to development of N<strong>ew Bioanalytical</strong

APA, Harvard, Vancouver, ISO, and other styles

12

Prasad, S. Nagaraja, and Vedavathi H. "Pharmacoeconomic study of antipsychotic drugs in India." International Journal of Basic & Clinical Pharmacology 6, no. 2 (2017): 377. http://dx.doi.org/10.18203/2319-2003.ijbcp20170333.

Full text

Abstract:

Background: Schizophrenia is a disorder of relatively high point prevalence, low incidence and high disability. It accounts for nearly 1.5-3% of total national expenditure on health care. There is a gross variation in the cost of various branded and generic versions of antipsychotics available in India. This can lead to decreased patient compliance. The present study was undertaken to highlight this variation in the cost of various preparations of antipsychotics (branded and generic) available in India.Methods: Cost ratio and Percentage variation in cost of various antipsychotics available wer

APA, Harvard, Vancouver, ISO, and other styles

13

Ahlund, S. E., and I. Gosai. "Use of amisulpride in clozapine-resistant schizophrenic patients: Three case reports." European Psychiatry 26, S2 (2011): 1338. http://dx.doi.org/10.1016/s0924-9338(11)73043-7.

Full text

Abstract:

IntroductionIt is generally accepted that Clozapine is the gold standard treatment in patients with treatment resistant schizophrenia. Large numbers of patients treated with Clozapine discontinue treatment for various reasons including severe side-effects and insufficient response. There is limited literature supporting the next-step treatment option following the discontinuation of Clozapine.ObjectivesThe atypical antipsychotic Amisulpride as a next-step treatment option beyond Clozapine, is hypothesised to be useful in some patients due to its first pass metabolism which differs from other s

APA, Harvard, Vancouver, ISO, and other styles

14

Rudzinski, Gracjan, Kinga Brzuszkiewicz, Kinga Pożarowska, et al. "On catatonia again... - literature review." Journal of Education, Health and Sport 24, no. 1 (2023): 53–66. http://dx.doi.org/10.12775/jehs.2023.24.01.005.

Full text

Abstract:

Introduction: In addition to the symptoms, the symptoms of catatonia have been classified as a subtype of schizophrenia (catatonic schizophrenia). Currently, however, catatonia is treated as a single psychopathological syndrome that can occur in the course of various disorders. Catatonia has been the subject of many disputes in the scientific community over the years, and many of its elements remain unexplored. Material and method: The aim of the study is to review current research on catatonia in the field of: main, leading to catatonia, neuroimaging, immunology, methods of treatment and psyc

APA, Harvard, Vancouver, ISO, and other styles

15

Gutierrez, F., C. Losada, M. López, et al. "Pysa syndrome: a case report." European Psychiatry 26, S2 (2011): 1243. http://dx.doi.org/10.1016/s0924-9338(11)72948-0.

Full text

Abstract:

Pisa syndrome is known to be a condition in which there is sustained involuntary flexion of the body and head to one side and slight rotation of the trunk so the person appears to lean like the Leaning Tower of Pisa.The development of Pisa syndrome is most commonly associated with prolonged treatment with antipsychotics. Although less frequently, Pisa syndrome has been reported, in patients who are receiving other medications (such as cholinesterase inhibitors and antiemetics), in those not receiving medication (idiopathic Pisa syndrome) and also patients with neurodegenerative disorders like

APA, Harvard, Vancouver, ISO, and other styles

16

Khouadja, S., R. Ben Soussia, S. Younes, A. Bouallagui, I. Marrag, and M. Nasr. "Ultra-resistant schizophrenia and potentiation strategies." European Psychiatry 41, S1 (2017): s834. http://dx.doi.org/10.1016/j.eurpsy.2017.01.1639.

Full text

Abstract:

IntroductionTreatment resistance to clozapine is estimated at 40–70% of the treated population. Several clozapine potentiation strategies have come into clinical practice although often without evidence-based support.ObjectiveThe aim of our work was to identify the potentiation strategies in ultra-resistant schizophrenia depending on the subtype of schizophrenia.MethodologyThis is a prospective study conducted on patients with the diagnosis of schizophrenia, based on DSM-IV-TR criteria, and hospitalized in the psychiatric department of the university hospital in Mahdia, Tunisia. The study samp

APA, Harvard, Vancouver, ISO, and other styles

17

Ogando Portilla, N., S. M. Bañón González, B. Gamo Bravo, M. E. González Laynez, M. A. Urbanos, and M. M. Cortés. "Cognitive impairment assessment in schizophrenia. purposely a case." European Psychiatry 67, S1 (2024): S755. http://dx.doi.org/10.1192/j.eurpsy.2024.1572.

Full text

Abstract:

Introduction Significant and measurable cognitive symptoms are present at the onset of the disorder and these remain stable in the subsequent period between 2 and 5 years. Their deterioration increases with the course of the disease. Attention, concentration, psychomotor speed and resolution of conceptual tasks are usually affected and are more significant in the presence of positive symptoms.Objectives Sometimes, the typical positive or negative symptoms of the disease do not adequately reflect the severity of cognitive impairment. Measuring this deterioration can be very relevant when evalua

APA, Harvard, Vancouver, ISO, and other styles

18

Concannon, C., P. Reynolds, and A. M. Meaney. "Visual hallucinations in the elderly: a case series and discussion of aetiology and treatment." Irish Journal of Psychological Medicine 33, no. 1 (2015): 33–41. http://dx.doi.org/10.1017/ipm.2015.9.

Full text

Abstract:

BackgroundVisual hallucinations are a common phenomenon, among the older adult population. They can be functional or organic in aetiology. However, new onset visual hallucinations in this population are strongly suggestive of organic brain disease. Visual impairment, cerebrovascular disease and Parkinson’s disease are three causes of visual hallucinations, considered in this case series. The evidence in the literature, for the treatment of these conditions is scant at best. There is a paucity of randomised controlled trials available concerning possible therapeutic options.Aims/MethodsWe descr

APA, Harvard, Vancouver, ISO, and other styles

19

Yerlikaya Oral, E. "Effective Use of Clozapine in Managing Treatment-Resistant Conduct Disorder in an Adolescent Patient: An Unconventional Approach." European Psychiatry 67, S1 (2024): S449. http://dx.doi.org/10.1192/j.eurpsy.2024.931.

Full text

Abstract:

IntroductionThis case report elaborates an unconventional approach to the management the use of clozapine, typically used in treatment-resistant Schizophrenia, in a 17-year-old female patient with treatment-resistant Conduct Disorder, Attention Deficit and Hyperactivity Disorder and Intellectual Disability.ObjectivesThe aim is to demonstrate the potential effectiveness and applicability of clozapine in treating severe, treatment-resistant behavioral problems associated with Conduct Disorder, even without the presence of psychosis, by detailing the clinical course, treatment strategy and outcom

APA, Harvard, Vancouver, ISO, and other styles

20

Maria-Silvia, T. M. S. "Metabolic syndrome in schizophrenia -impact of antipsychotic medication." European Psychiatry 26, S2 (2011): 1255. http://dx.doi.org/10.1016/s0924-9338(11)72960-1.

Full text

Abstract:

Metabolic syndrome generally includes some or all of the following: elevated blood pressure, abdominal obesity, diabetes or “prediabetes” (impaired glucose tolerance, impaired fasting glucose or insulin resistance), dyslipidemia (high levels of triglycerides and/or HDL), and inflammatory markersP.S. a 34 year old, diagnosed with Paranoid schizophrenia. The patient comes from a disorganised family. The disease started at 18 years with psychotic symptoms - delirious, psychotic behavior, aggression, neglect of personal hygiene. He received almost continuous antipsychotic medication. In recent yea

APA, Harvard, Vancouver, ISO, and other styles

21

"P.3.056 Improving the parasympathetic activity during switched from typical antipsychotic agents to amisulpiride." European Neuropsychopharmacology 15 (January 2005): S479. http://dx.doi.org/10.1016/s0924-977x(05)80992-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Kambuzuma, Paidamoyo, and Belinda Marais. "A case of clozapine-induced stuttering in a HIV-positive individual." South African Journal of Psychiatry 31 (July 17, 2025). https://doi.org/10.4102/sajpsychiatry.v31i0.2462.

Full text

Abstract:

Introduction: Stuttering, a speech disorder marked by disruptions in fluency, can be developmental or acquired. Acquired stuttering often stems from neurological causes, psychological trauma or certain medications, with antipsychotics such as clozapine implicated in several cases. Clozapine, particularly at higher doses, has been associated with dose-dependent stuttering although the precise mechanisms remain uncertain. While clozapine’s effects dopamine pathways and seizure thresholds are proposed mechanisms, movement disorders such as focal dystonia and prior extrapyramidal symptoms (EPSEs)

APA, Harvard, Vancouver, ISO, and other styles

23

Zarghami, Mehran, Nasrin Dodangi, Paria Azari, and Alireza Khalilian. "Antipsychotic Effects of Celecoxib Add-On Haloperidol in Schizophrenia: A Randomized Double-Blind Placebo-Controlled Clinical Trial." Iranian Journal of Psychiatry and Behavioral Sciences 18, no. 1 (2024). http://dx.doi.org/10.5812/ijpbs-138643.

Full text

Abstract:

Background: Previous studies have indicated abnormalities in the immune system, such as central nervous system inflammation and high levels of activating cytokines in the cerebrospinal fluid of schizophrenic patients. Celecoxib, a modulator of proinflammatory cytokines, as an adjunctive therapy add-on risperidone (a well-established atypical antipsychotic) and amisulpiride (a benzamide antipsychotic), had improved these patients significantly. Objectives: A trial was conducted to evaluate the therapeutic effects of celecoxib add-on haloperidol, a classic antipsychotic that has been reported to

APA, Harvard, Vancouver, ISO, and other styles

24

RUDZINSKI, Gracjan, Kinga BRZUSZKIEWICZ, Kinga POŻAROWSKA, et al. "On catatonia again... - literature review." 24, no. 1 (2023): 53–66. https://doi.org/10.12775/JEHS.2023.24.01.005.

Full text

Abstract:

<strong>RUDZINSKI, Gracjan, BRZUSZKIEWICZ, Kinga, POŻAROWSKA, Kinga, KUSAK, Natalia, ŁOZOWSKI, Borys, SZCZEPANIAK-WÓJTOWICZ, Elżbieta & SOROKA, Ewelina. On catatonia again.</strong><strong>..</strong><strong> - literature review</strong><strong>.</strong> <strong>Journal of Education, Health and Sport. 2023;</strong><strong>24</strong><strong>(1):</strong><strong>53-66</strong><strong>. eISSN 2391-8306. DOI </strong><strong>http://dx.doi.org/10.12775/JEHS.2023.24.01.00</strong><strong>5</strong> <strong>https://apcz.umk.pl/JEHS/article/view/43</strong><strong>428</strong>

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!